Preventive effect of central administration of venlafaxine on morphine physical dependence, nociception, and blood cortisol level in rat

International Journal of Preventive Medicine

Volumn 5, Issue 11, 2014, Pages 1422-1431

  Motaghinejad, Majid ^a   Ebrahimzadeh, Andia ^a   Shabab, Behnaz ^b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IranNajo Pharmaceutical Co   (Iran)

Author keywords

Morphine; Pain; Venlafaxine; Withdrawal syndrome

Indexed keywords

HYDROCORTISONE; INDOMETACIN; MORPHINE; VENLAFAXINE;

ADULT; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HOT PLATE TEST; HYDROCORTISONE BLOOD LEVEL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MORPHINE ADDICTION; NOCICEPTION; NONHUMAN; PAIN; RAT; SINGLE DRUG DOSE; TAIL FLICK TEST; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; WRITHING TEST;

EID: 84914098518     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ferrini F, Trang T, Mattioli TA, Laffray S, Del’Guidice T, Lorenzo LE, et al. Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl? homeostasis. Nat Neurosci 2013;16:183-92.
2. Dang VC, Chieng B, Azriel Y, Christie MJ. Cellular morphine tolerance produced by ßarrestin-2-dependent impairment of i-opioid receptor resensitization. J Neurosci 2011;31:7122-30.
3. Goeldner C, Lutz PE, Darcq E, Halter T, Clesse D, Ouagazzal AM, et al. Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry 2011;69:236-44.
4. Parkitna JR, Solecki W, Golembiowska K, Tokarski K, Kubik J, Golda S, et al. Glutamate input to noradrenergic neurons plays an essential role in the development of morphine dependence and psychomotor sensitization. Int J Neuropsychopharmacol 2012;15:1457-71.
5. Mati nfar M, Esfahani MM, Aslany N, Davoodi SH, Parsaei P, Zarei G, et al. Effect of repeated morphine withdrawal on spatial learning, memory and serum cortisol level in mice. Adv Biomed Res 2013;2:80.
6. Motaghinejad M, Motaghinejad O. Preventive effects of forced exercise against alcohol induced physical dependency and reduction of pain perception threshold. Int J Prev Med 2014. [Assigned to October Issue].
7. Almela P, Navarro-Zaragoza J, García-Carmona JA, Mora L, Hidalgo J, Milanés MV, et al. Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc). PLoS One 2012;7:e47089.
8. Navarro-Zaragoza J, Núñez C, Laorden ML, Milanés MV. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal. Mol Pharmacol 2010;77:864-73.
9. Laorden M L, Ferenczi S, Pintér-Kübler B, González-Martín LL, Lasheras MC, Kovács KJ, et al. Hypothalamic orexin - a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One 2012;7:e36871.
10. Zhang W, Hu C-Y, Gan W-Y. The effects of venlafaxin on the depressive symptoms and cognition function of Parkinson’s disease. Pract J Card Cereb Pneumonol Vasc Dis 2010;8:12.
11. Ciraulo DA, Barlow DH, Gulliver SB, Farchione T, Morissette SB, Kamholz BW, et al. The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders. Behav Res Ther 2013;51:729-35.
12. Amr YM, Yousef AA. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain 2010;26:381-5.
13. Aricioglu F, Buldanlioglu U, Salanturoglu G, Ozyalçin NS. Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat. Agri 2005;17:41-6.
14. Treister R, Pud D, Ebstein RP, Laiba E, Raz Y, Gershon E, et al. Association between polymorphisms in serotonin and dopamine-related genes and endogenous pain modulation. J Pain 2011;12:875-83.
15. Sommer C. Serotonin in pain and pain control. Handbook of the Behavioral Neurobiology of Serotonin. London: Elsevier; 2010. p. 457-71.
16. Li W, Shi X, Wang L, Guo T, Wei T, Cheng K, et al. Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome. Pain 2013;154:1224-36.
17. Cegielska-Perun K, Bujalska-Zadrozny M, Makulska-Nowak HE. Modification of morphine analgesia by venlafaxine in diabetic neuropathic pain model. Pharmacol Rep 2012;64:1267-75.
18. Ozdemir E, Gursoy S, Bagcivan I. The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats. J Physiol Sci 2012;62:317-23.
19. Sikka P, Kaushik S, Kumar G, Kapoor S, Bindra VK, Saxena KK. Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice. J Pharm Bioallied Sci 2011;3:412-6.
20. Parvizpour A, Charkhpour M, Habibi-asl B, Shakhsi M, Ghaderi M, Hassanzadeh K. Repeated central administration of selegiline attenuated morphine physical dependence in rat. Pharmacol Rep 2013;65:593-9.
21. Deciga-Campos M, González-Trujano E, Navarrete A, Mata R. Antinociceptive effect of selected Mexican traditional medicinal species. Proc West Pharmacol Soc 2005;48:70-2.
22. Silva ML, Silva JR, Prado WA. Retrosplenial cortex is involved in analgesia induced by 2-but not 100-Hz electroacupuncture in the rat tail-flick test. J Acupunct Meridian Stud 2012;5:42-5.
23. Chavan MJ, Wakte PS, Shinde DB. Analgesic and anti-inflammatory activity of Caryophyllene oxide from Annona squamosa L. bark. Phytomedicine 2010;17:149-51.
24. Colvin L, Carty S. Neuropathic Pain. ABC of Pain. Wiley Publisher 2012. p. 43.
25. Durand JP, Deplanque G, Montheil V, Gornet JM, Scotte F, Mir O, et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: Results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 2012;23:200-5.
26. Levin FR, Mariani J, Brooks DJ, Pavlicova M, Nunes EV, Agosti V, et al. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction 2013;108:1084-94.
27. Raby WN, Rubin EA, Garawi F, Cheng W, Mason E, Sanfilippo L, et al. A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients. Am J Addict 2014;23:68-75.
28. Berridge CW, Waterhouse BD. The locus coeruleusnoradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 2003;42:33-84.
29. Varani AP, Aso E, Moutinho LM, Maldonado R, Balerio GN. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations. Psychopharmacology (Berl) 2014;231:3031-40.
30. Upadhyaya HP, Brady KT, Sethuraman G, Sonne SC, Malcolm R. Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/ hyperactivity disorder: A pilot study. J Clin Psychopharmacol 2001;21:116-8.
31. Martínez-Laorden E, Hurle MA, Milanés MV, Laorden ML, Almela P. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: The role of extracellular signal-regulated kinase. J Pharmacol Exp Ther 2012;342:665-75.
32. Rickels K, Etemad B, Rynn MA, Lohoff FW, Mandos LA, Gallop R. Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR. Psychother Psychosom 2013;82:363-71.
33. Gorman JM. Treatment of generalized anxiety disorder. J Clin Psychiatry 2002;63 Suppl 8:17-23.
34. Miranda HF, Lemus I, Pinardi G. Effect of the inhibition of serotonin biosynthesis on the antinociception induced by nonsteroidal anti-inflammatory drugs. Brain Res Bull 2003;61:417-25.
35. Boyce-Rustay JM, Zhong C, Kohnken R, Baker SJ, Simler GH, Wensink EJ, et al. Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. Neuropharmacology 2010;58:537-43.
36. Lee YC, Chen PP. A review of SSRIs and SNRIs in neuropathic pain. Expert Opin Pharmacother 2010;11:2813-25.
37. Wolfe MD, O’Connor AB. Management of neuropathic pain in hospitalized patients. Hosp Med Clin 2013;2:e587-602.
38. Faure C, Patey N, Gauthier C, Brooks EM, Mawe GM. Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology 2010;139:249-58.
39. Sommer C. Serotonin in pain and analgesia: Actions in the periphery. Mol Neurobiol 2004;30:117-25.
40. Mochizucki D. Ser otonin and noradrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol 2004;19 Suppl 1:S15-9.
41. Zhang X, Liu C-Y, Wang Y-N, Guan S-L, Wang Z-Q. Effect of venlafaxine on apoptosis and cell cycle of rat hippocampus neurons. J Jilin Univ (Medicine Edition) 2011;4:002.
42. Gaur V, Kumar A. Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: Possible involvement of NO-cGMP pathway. Brain Res 2010;1353:204-12.